Name | Number of supported studies | Average coverage | |
|---|---|---|---|
| retinal bipolar neuron | 3 studies | 69% ± 27% | |
| ON-bipolar cell | 3 studies | 59% ± 20% | |
| rod bipolar cell | 3 studies | 73% ± 20% | |
| brush cell | 3 studies | 51% ± 15% |
Name | Number of supported studies | Average coverage | |
|---|---|---|---|
| eye | 3 studies | 20% ± 4% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
|---|---|---|---|---|---|---|
| brain | 56% | 452.58 | 1471 / 2642 | 43% | 1.78 | 305 / 705 |
| prostate | 0% | 0.14 | 1 / 245 | 51% | 2.38 | 254 / 502 |
| intestine | 25% | 18.22 | 240 / 966 | 17% | 0.63 | 90 / 527 |
| breast | 0% | 0 | 0 / 459 | 37% | 2.71 | 410 / 1118 |
| ovary | 1% | 0.56 | 1 / 180 | 26% | 0.67 | 112 / 430 |
| pancreas | 0% | 0 | 0 / 328 | 26% | 0.68 | 46 / 178 |
| eye | 0% | 0 | 0 / 0 | 15% | 2.79 | 12 / 80 |
| thymus | 0% | 0 | 0 / 653 | 11% | 2.42 | 69 / 605 |
| stomach | 1% | 0.21 | 2 / 359 | 9% | 0.98 | 26 / 286 |
| uterus | 0% | 0 | 0 / 170 | 9% | 0.24 | 41 / 459 |
| tonsil | 0% | 0 | 0 / 0 | 9% | 0.13 | 4 / 45 |
| bladder | 0% | 0 | 0 / 21 | 8% | 0.34 | 42 / 504 |
| lung | 0% | 0 | 0 / 578 | 8% | 0.24 | 89 / 1155 |
| esophagus | 0% | 0 | 0 / 1445 | 5% | 0.21 | 10 / 183 |
| adrenal gland | 0% | 0.94 | 1 / 258 | 3% | 0.32 | 8 / 230 |
| lymph node | 0% | 0 | 0 / 0 | 3% | 0.04 | 1 / 29 |
| skin | 0% | 0.17 | 3 / 1809 | 2% | 0.03 | 9 / 472 |
| kidney | 0% | 0 | 0 / 89 | 1% | 0.02 | 5 / 901 |
| liver | 0% | 0 | 0 / 226 | 0% | 0.00 | 1 / 406 |
| peripheral blood | 0% | 0.08 | 1 / 929 | 0% | 0 | 0 / 0 |
| abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| adipose | 0% | 0 | 0 / 1204 | 0% | 0 | 0 / 0 |
| blood vessel | 0% | 0 | 0 / 1335 | 0% | 0 | 0 / 0 |
| bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| heart | 0% | 0 | 0 / 861 | 0% | 0 | 0 / 0 |
| muscle | 0% | 0 | 0 / 803 | 0% | 0 | 0 / 0 |
| nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| spleen | 0% | 0 | 0 / 241 | 0% | 0 | 0 / 0 |
| ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
| GO_0007186 | Biological process | G protein-coupled receptor signaling pathway |
| GO_0007200 | Biological process | phospholipase C-activating G protein-coupled receptor signaling pathway |
| GO_0050909 | Biological process | sensory perception of taste |
| GO_0005834 | Cellular component | heterotrimeric G-protein complex |
| GO_0005886 | Cellular component | plasma membrane |
| GO_0030425 | Cellular component | dendrite |
| GO_0031681 | Molecular function | G-protein beta-subunit binding |
| GO_0005515 | Molecular function | protein binding |
| Gene name | GNG13 |
| Protein name | Guanine nucleotide-binding protein G(I)/G(S)/G(O) subunit gamma-13 |
| Synonyms | |
| Description | FUNCTION: Guanine nucleotide-binding proteins (G proteins) are involved as a modulator or transducer in various transmembrane signaling systems. The beta and gamma chains are required for the GTPase activity, for replacement of GDP by GTP, and for G protein-effector interaction. |
| Accessions | ENST00000248150.5 Q9P2W3 |